CJC 1295 without Dac 5mg + IPA5mg 10mg

Comprehensive Guide to CJC-1295 Without DAC (5mg) + Ipamorelin (5mg) Blend 10mg: Growth Hormone Secretagogue Structure, Pituitary Axis Research Standards, and Analytical Purity

Welcome to Suzhou Lanhai Peptide, your trusted global source for advanced synthetic peptides, amino acid derivatives, and specialized laboratory storage solutions. In modern endocrinology research, pulsatile growth hormone secretion studies, and advanced pharmaceutical formulation research, investigating targeted growth hormone secretagogue receptor (GHSR) agonists and GHRH analogues requires absolute precision, verifiable purity, and strict compliance with research standards. When exploring synergistic pituitary stimulation, somatotrophic axis dynamics, and nitrogen retention pathways, utilizing high-purity CJC-1295 Without DAC (5mg) + Ipamorelin (5mg) Blend 10mg is vital for achieving reproducible scientific outcomes.

This comprehensive guide explores the structural sequences, biochemical properties, analytical verification standards, and proper laboratory storage protocols for this dual-peptide research blend. By examining real-world industry benchmarks and analytical chemistry standards, we outline why optimized sourcing and handling are fundamental to advanced endocrine and metabolic research.

1. Understanding the CJC-1295 Without DAC + Ipamorelin Blend: Structure, Mechanism, and Research Scope

This research formulation combines two distinct, highly synergistic synthetic peptides designed to stimulate the endogenous release of growth hormone (GH) via complementary receptor pathways:

1. CJC-1295 Without DAC (Mod GRF 1-29): A modified 29-amino acid peptide analogue of human Growth Hormone-Releasing Hormone (GHRH). Unlike its DAC-conjugated counterpart, Mod GRF 1-29 has a short half-life designed to induce short, natural, pulsatile spikes in growth hormone secretion, mimicking natural physiological rhythms.

2. Ipamorelin: A selective, highly specific pentapeptide ghrelin receptor (GHSR-1a) agonist. It stimulates GH release directly from the anterior pituitary while exhibiting minimal impact on cortisol, prolactin, or appetite-stimulating pathways compared to earlier ghrelin mimetics.

The Mechanism of Action in Biomedical Research

In contemporary biochemical and pharmacological investigations, this dual-peptide combination is examined for several key cellular pathways:

• Synergistic Pituitary Activation: CJC-1295 (GHRH analogue) and Ipamorelin (ghrelin mimetic) bind to separate receptors on pituitary somatotroph cells, producing a synergistic amplification of growth hormone release that significantly exceeds the impact of either compound administered independently.

• Pulsatile Secretion Dynamics: Research demonstrates that avoiding long-acting affinity tags (such as DAC) preserves normal negative feedback loops and prevents pituitary desensitization, allowing researchers to study natural secretory pulse amplitudes.

• Anabolic and Body Composition Studies: In vitro and animal model research evaluates its influence on protein synthesis, nitrogen retention, collagen synthesis, and lean tissue preservation during catabolic disease or aging models.

2. Analytical Verification and High-Purity Synthesis Standards

For institutional buyers, academic researchers, and biotechnology procurement managers, batch verification is paramount. Blended synthetic peptide formulations require rigorous solid-phase peptide synthesis (SPPS), individual HPLC purification prior to compounding, and strict mass spectrometry confirmation to ensure precise mass ratios and structural integrity.

High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)

Every batch of the CJC-1295 without DAC (5mg) + Ipamorelin (5mg) blend distributed by Suzhou Lanhai Peptide undergoes rigorous verification via HPLC and MS to guarantee individual and combined purity levels exceeding 98% to 99%+, ensuring minimal synthetic impurities, truncated fragments, or incorrect ratio distributions.

Technical Specification Comparison

Specification Parameter	Standard Research Grade	Premium Analytical Grade
Peptide Components	Mod GRF 1-29 (5mg) + Ipamorelin (5mg)	Mod GRF 1-29 (5mg) + Ipamorelin (5mg)
Combined Formulation	10mg Total Lyophilized Blend / Vial	10mg Total Lyophilized Blend / Vial
Purity (HPLC)	$\ge 98.0\%$ (Each Component)	$\ge 99.2\%$ (Each Component)
Mass Spectrometry (MS)	Verified Molecular Weights	Verified Molecular Weights
Storage Conditions	$-20^\circ C$ desiccated, dark	$-20^\circ C$ desiccated, dark

3. Laboratory Handling, Reconstitution, and Storage Protocols

Blended synthetic peptides are supplied as stabilized, vacuum-freeze-dried (lyophilized) powders to maximize shelf-life stability. Proper laboratory handling is essential to preserve peptide integrity upon reconstitution.

Reconstitution Best Practices

• Solvent Selection: Reconstitute the lyophilized 10mg blend using sterile bacteriostatic water for injection or analytical buffer solutions in a clean laminar flow hood.

• Avoiding Shear Stress: Introduce solvents gently down the inside wall of the vial rather than forcefully spraying liquid directly onto the lyophilized cake to prevent peptide bond shearing.

Cold-Chain Storage Guidelines

• Dry Powder Storage: Store sealed vials of the lyophilized peptide blend at $-20^\circ C$ desiccated away from light and moisture.

• Reconstituted Storage: Once reconstituted, solutions should be kept between $2^\circ C$ and $8^\circ C$ protected from light and utilized within short-term experimental windows to prevent enzymatic degradation.

4. Mandatory Research Disclaimer and Compliance

• For Laboratory and Research Use Only: All peptide products offered by Suzhou Lanhai Peptide, including the CJC-1295 without DAC + Ipamorelin blend, are strictly intended for in vitro laboratory research, analytical testing, and scientific study. They are not approved for human consumption, clinical trials on humans, veterinary use, or therapeutic self-administration.

5. Frequently Asked Questions (FAQs)

1. What is the advantage of combining CJC-1295 without DAC with Ipamorelin?

Combining a GHRH analogue (CJC-1295 without DAC) and a ghrelin receptor agonist (Ipamorelin) targets two distinct pathways on the pituitary gland, creating a synergistic release of growth hormone that mirrors natural pulsatile secretion.

2. What purity level does Suzhou Lanhai Peptide guarantee for this blend?

Every batch of the CJC-1295 / Ipamorelin blend is backed by analytical documentation confirming an HPLC purity rating of 98% to 99% or higher for both constituent peptides.

3. How should the lyophilized 10mg blend vial be stored prior to reconstitution?

Vials of dry powder should be stored tightly sealed in a dry environment at $-20^\circ C$ protected from light to maintain structural stability.

4. Are Certificates of Analysis (COAs) provided with orders?

Yes. Every order includes or provides access to batch-specific HPLC and Mass Spectrometry reports verifying the purity and exact mass ratios of both components for institutional compliance.

5. Can this peptide blend be used in human clinical applications?

No. All products sold by Suzhou Lanhai Peptide are restricted strictly to laboratory research and development use only and are prohibited from human or clinical application.